Global Bioprocess Containers Market Overview

The Global Bioprocess Containers market was valued at USD 2.14 billion in 2023 and is expected to reach USD 4.18 billion by the year 2032, at a CAGR of 12.2%.

Thermo Scientific Bioprocess Containers (BPCs) and transfer assemblies are ready-to-use single-use flexible container systems for critical liquid handling utilization in biopharmaceutical and biomanufacturing operations. Applications for bioprocess containers have raised adequately over the past few years as the demand for single-use solutions for pharmaceutical and bioprocessing production has increased. For example, Saint Gobain has an extensive range of bioprocess bag solutions ranging from small 25ml cell culture bags, right up to 3000L bags for larger volume applications. Furthermore, key factors imputing to the growth of the market are the increase in the global prevalence of cancer and immunological disorder cases that necessitate the need for vaccines and biologics associated with the raised preference for Immunotherapy to the Chemotherapy accelerate the demand for the bioprocess containers.

For instance, as per the American Cancer Society report, in 2019, about 1,762,450 new cancer cases were identified and 606,880 cancer deaths registered in the United States demanding treatment with novel and efficient methods. In addition, an increase in the approval of new drugs by the FDA and the introduction of new products in the forecast period and is expected to offer profitable opportunities that accelerate market growth worldwide. Moreover, the advancements in single-use bioprocess technologies increased the inexpensive and sustainability of vaccine production along with a reduction in the risk of cross-contamination is anticipated to stimulate the market over the projected period.

COVID-19 Impact on Global Bioprocess Containers Market

COVID-19 pandemic adversely affected almost all over sectors globally. The novel coronavirus outbreak began in Wuhan (China) in December 2019, COVID-19 has since shifted from being a regional crisis to a global pandemic. As the World Health Organization (WHO) officially announced the outbreak of the virus as a pandemic, a mix of established pharmaceutical companies, as well as players in the bioprocess containers market, have moved forward to produce treatments and vaccines that focus on the infection caused by the novel coronavirus. As long as most of the top COVID-19 vaccine programs are utilizing novel applications, comprising mRNA, DNA vaccine, and vectors, these platforms are majorly built on single-use technology. Most of the COVID-19 related latest units are largely captivating single-use systems owing to their flexibility combined with high speed and much lower capital investment compared to traditional stainless-steel equipment. Hence, the rising adoption of single-use technologies for COVID-19 pandemic-related research, coupled with growing vaccine development by key players, is anticipated to have a positive impact on the global bioprocess containers market.

Market Dynamics and Forecast for the Global Bioprocess Containers Market

Drivers:

Growth in demand for biologics drives the global bioprocess containers market. New biologics are being expanded for the treatment of diabetes, cancer, and other serious medical conditions. Investment by biopharmaceutical companies and an increase in the incidence of chronic diseases are the factors fueling the growth of biologics. Bioprocess container components are readily integrated into different high-performance systems for all steps in the production of biologics. Therefore, an increase in demand for biologics stimulates market growth.

Vaccine manufacturing using single-use disposable technologies is another factor that turns the market in terms of revenue. Single-use technology (SUT) products are extensively accepted for the production of vaccines and also for biologics, due to demonstrated performance and cost- and timesaving significance. Single-use technology devices provide importance such as fewer cleaning and sterilization processes, declined cross-contamination risks, and shorter setup times. An increase in the requirement of vaccine production using single-use technology (SUT) products trigger the growth of the market.

The growth of single-use technologies can be attributed to the rising requirement for better, cheaper, and faster biologics production. Active development of individualized biologics and personalized medicines, comprising patient-specific cellular & gene therapies and therapeutic vaccines, demands high sterility and is therefore produced using single-use equipment and consumables. The COVID-19 pandemic caused the extraordinary demand for vaccines. The pandemic, in turn, has increased the application of large-scale and laboratory-scale single-use bioreactors and associated consumables such as media bags, bioprocess containers, filtration assemblies, and other consumables.

Restraints:

Massive problems related to leachable and extractable bioprocess containers, implementation of strict regulatory policies toward production practice of bioprocess containers, and high cost of instruments pose a major restraint for the growth of the market. Compared to traditional bio-manufacturing technologies, single-use systems (SUS) have many advantages, such as declined deeds for process validation and higher manufacturing flexibility, which eventually results in higher operating efficiency and decreased manufacturing costs. Despite this importance, there is a possibility that the plastic materials used for SUS may leach organic compounds or inorganic substances into the processing fluid or the final drug product, which remains a key concern. Such an undesired change could eventually compromise bioprocessing and might adversely impact the quality, safety, and purity of the drug product.

Opportunities:

The patent expiry of blockbuster drugs has followed in raised R&D spending by pharmaceutical and biotechnology companies. Patent expiry of biologics leads to rising R&D of biologics and change biologics from the pipeline to commercial production. As the development and production costs of biologics are very high, companies are now moderately targeting techniques that are more economical than traditional biomanufacturing methods.  Consequently, different biopharmaceutical manufacturers are including single-use bioprocessing technologies in their development processes. By using single-use bioprocessing assemblies such as bioprocess containers, biomanufacturing companies can develop inventive products at inexpensive budgets that fulfill customer requirements and demands. Moreover, in combination with continuous DSP and disposable technologies, it creates the opportunity for small-scale production processes of low investments costs and risks. Additionally, the creation of high-volume cell banks could also be attained resulting in a diminished bioreactor train in manufacturing processes.

Market Segmentation

Segmentation Analysis of Global Bioprocess Containers Market:

Based on Type, the 2D bioprocess containers segment is expected to register the maximum market share of the global bioprocess containers market during the forecast period. 2D bioprocess containers are often used in cell harvesting and for the transportation of bulk drug products and bulk drug precursors.

Based on Application, the upstream processes segment is expected to dominate the global bioprocess containers market during the forecast period. The upstream processes segment is anticipated to grow at the highest CAGR during the forecasted period. The upstream process is accounted for in the first stage of the bioprocess, from cell line development and cultivation to culture extension of the cells through harvest. Growth in the number of cell researches improves the augment in the upstream processes segment. Upstream processes make the highest usage of bioprocess containers, primarily during fermentation and culture media processing; owing to this, this segment holds the maximum market share.

Based on End-Users, the pharmaceutical & biopharmaceutical companies segment is expected to register the largest market share of the global bioprocess containers market. The demand for biopharmaceuticals among the senior population is growing as the elderly are more prone to various diseases/disorders that can be treated using biologics. This has followed in the rising attention of biopharmaceutical companies emerging affordable biologics at lower costs. As bioprocess containers have extensive applications in research & process advancement, the adoption of BPCs is increasing with the growth in the development and production of biologics and biosimilars.

Regional Analysis of Global Bioprocess Containers Market:

North America is anticipated to dominate the overall bioprocess container market over the projected period. This dominance is mainly due to the strong demand for biopharmaceuticals owing to the increase in the geriatric population and advanced health care infrastructure in the United States. In addition, owing to the presence of leading players targeting research activities and massive investments in health care by manufacturers based in the United States contributes to its magnificent market growth globally.

North America followed by Europe holds the second-highest market globally with an increase in the life science R&D companies and manufacturing units of biologics and biosimilars in the region. Thus, the requirement of bioprocess containers raised significantly to overcome the process complications and contamination risks primarily contribute to the growth of the market in the region accelerating the global market.

The Asia Pacific market is expected to observe the maximum market share during the projected period due to the significant investments by key market players coupled with the rising government support in the region. The latest developments in countries such as India, China, and Japan with a high R&D infrastructure of pharmaceutical manufacturing and comparatively cheaper labor costs accelerate the market revenue. For example, in May 2017, Merck began its first joint bioprocess Scale-Up laboratory in Bengaluru, India with Stelis Biopharma to offer end-to-end solutions for pre-clinical, clinical, and commercial supply indicating massive development for the market in the region.

Players Covered in Bioprocess Containers Market are:

• Thermo Fisher Scientific
• Danaher Corporation
• Sartorius Stedim Biotech
• Rim Bio
• Finesse Solutions
• Optimum Processing Inc.
• Merck Millipore
• PARKER HANNIFIN CORP
• Lonza Group AG
• Avantor Inc.
• General Electric Company
• Saint- Gobain S.A.
• GE Healthcare
• GE Healthcare
• Meissner
• Fluids Control
• Neta Scientific Incorporated Inc.
• ALLpaQ Packaging Group
• Others major Players.

Key Industry Developments in Global Bioprocess Containers Market

• IIn July 2024, Duoning Biotechnology Group ("Duoning"), a leading one-stop bioprocess solution provider, announced it has attended at Interphex Korea 2024 to showcase its total bioprocess solutions for the preparation of diverse biological products. Interphex 2024 provides an opportunity for a wide range of life science industry leaders to explore the optimal process for developing biological products.

Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application
 3.3 By End-Users

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: Bioprocess Containers Market by Type
 5.1 Bioprocess Containers Market Overview Snapshot and Growth Engine
 5.2 Bioprocess Containers Market Overview
 5.3 2D Bioprocess Containers
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2028F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 2D Bioprocess Containers: Grographic Segmentation
 5.4 3D Bioprocess Containers
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2028F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 3D Bioprocess Containers: Grographic Segmentation
 5.5 Tank Liners
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2028F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Tank Liners: Grographic Segmentation
 5.6 Others
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2028F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Others: Grographic Segmentation

Chapter 6: Bioprocess Containers Market by Application
 6.1 Bioprocess Containers Market Overview Snapshot and Growth Engine
 6.2 Bioprocess Containers Market Overview
 6.3 Process Development
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2028F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Process Development: Grographic Segmentation
 6.4 Upstream
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2028F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Upstream: Grographic Segmentation
 6.5 Downstream
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2028F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Downstream: Grographic Segmentation

Chapter 7: Bioprocess Containers Market by End-Users
 7.1 Bioprocess Containers Market Overview Snapshot and Growth Engine
 7.2 Bioprocess Containers Market Overview
 7.3 Pharmaceutical Companies
  7.3.1 Introduction and Market Overview
  7.3.2 Historic and Forecasted Market Size (2016-2028F)
  7.3.3 Key Market Trends, Growth Factors and Opportunities
  7.3.4 Pharmaceutical Companies: Grographic Segmentation
 7.4 Biopharmaceutical Companies
  7.4.1 Introduction and Market Overview
  7.4.2 Historic and Forecasted Market Size (2016-2028F)
  7.4.3 Key Market Trends, Growth Factors and Opportunities
  7.4.4 Biopharmaceutical Companies: Grographic Segmentation
 7.5 CMOS & CROS
  7.5.1 Introduction and Market Overview
  7.5.2 Historic and Forecasted Market Size (2016-2028F)
  7.5.3 Key Market Trends, Growth Factors and Opportunities
  7.5.4 CMOS & CROS: Grographic Segmentation
 7.6 Academic & Research Institute
  7.6.1 Introduction and Market Overview
  7.6.2 Historic and Forecasted Market Size (2016-2028F)
  7.6.3 Key Market Trends, Growth Factors and Opportunities
  7.6.4 Academic & Research Institute: Grographic Segmentation
 7.7 Others
  7.7.1 Introduction and Market Overview
  7.7.2 Historic and Forecasted Market Size (2016-2028F)
  7.7.3 Key Market Trends, Growth Factors and Opportunities
  7.7.4 Others: Grographic Segmentation

Chapter 8: Company Profiles and Competitive Analysis
 8.1 Competitive Landscape
  8.1.1 Competitive Positioning
  8.1.2 Bioprocess Containers Sales and Market Share By Players
  8.1.3 Industry BCG Matrix
  8.1.4 Ansoff Matrix
  8.1.5 Bioprocess Containers Industry Concentration Ratio (CR5 and HHI)
  8.1.6 Top 5 Bioprocess Containers Players Market Share
  8.1.7 Mergers and Acquisitions
  8.1.8 Business Strategies By Top Players
 8.2 THERMO FISHER SCIENTIFIC
  8.2.1 Company Overview
  8.2.2 Key Executives
  8.2.3 Company Snapshot
  8.2.4 Operating Business Segments
  8.2.5 Product Portfolio
  8.2.6 Business Performance
  8.2.7 Key Strategic Moves and Recent Developments
  8.2.8 SWOT Analysis
 8.3 DANAHER CORPORATION
 8.4 SARTORIUS STEDIM BIOTECH
 8.5 RIM BIO
 8.6 FINESSE SOLUTIONS
 8.7 OPTIMUM PROCESSING INC.
 8.8 MERCK MILLIPORE
 8.9 PARKER HANNIFIN CORP
 8.10 LONZA GROUP AG
 8.11 AVANTOR INC.
 8.12 GENERAL ELECTRIC COMPANY
 8.13 SAINT- GOBAIN S.A.
 8.14 GE HEALTHCARE
 8.15 MEISSNER
 8.16 FLUIDS CONTROL
 8.17 NETA SCIENTIFIC INCORPORATED INC.
 8.18 ALLPAQ PACKAGING GROUP
 8.19 OTHER MAJOR PLAYERS

Chapter 9: Global Bioprocess Containers Market Analysis, Insights and Forecast, 2016-2028
 9.1 Market Overview
 9.2 Historic and Forecasted Market Size By Type
  9.2.1 2D Bioprocess Containers
  9.2.2 3D Bioprocess Containers
  9.2.3 Tank Liners
  9.2.4 Others
 9.3 Historic and Forecasted Market Size By Application
  9.3.1 Process Development
  9.3.2 Upstream
  9.3.3 Downstream
 9.4 Historic and Forecasted Market Size By End-Users
  9.4.1 Pharmaceutical Companies
  9.4.2 Biopharmaceutical Companies
  9.4.3 CMOS & CROS
  9.4.4 Academic & Research Institute
  9.4.5 Others

Chapter 10: North America Bioprocess Containers Market Analysis, Insights and Forecast, 2016-2028
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 2D Bioprocess Containers
  10.4.2 3D Bioprocess Containers
  10.4.3 Tank Liners
  10.4.4 Others
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Process Development
  10.5.2 Upstream
  10.5.3 Downstream
 10.6 Historic and Forecasted Market Size By End-Users
  10.6.1 Pharmaceutical Companies
  10.6.2 Biopharmaceutical Companies
  10.6.3 CMOS & CROS
  10.6.4 Academic & Research Institute
  10.6.5 Others
 10.7 Historic and Forecast Market Size by Country
  10.7.1 U.S.
  10.7.2 Canada
  10.7.3 Mexico

Chapter 11: Europe Bioprocess Containers Market Analysis, Insights and Forecast, 2016-2028
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 2D Bioprocess Containers
  11.4.2 3D Bioprocess Containers
  11.4.3 Tank Liners
  11.4.4 Others
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Process Development
  11.5.2 Upstream
  11.5.3 Downstream
 11.6 Historic and Forecasted Market Size By End-Users
  11.6.1 Pharmaceutical Companies
  11.6.2 Biopharmaceutical Companies
  11.6.3 CMOS & CROS
  11.6.4 Academic & Research Institute
  11.6.5 Others
 11.7 Historic and Forecast Market Size by Country
  11.7.1 Germany
  11.7.2 U.K.
  11.7.3 France
  11.7.4 Italy
  11.7.5 Russia
  11.7.6 Spain
  11.7.7 Rest of Europe

Chapter 12: Asia-Pacific Bioprocess Containers Market Analysis, Insights and Forecast, 2016-2028
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 2D Bioprocess Containers
  12.4.2 3D Bioprocess Containers
  12.4.3 Tank Liners
  12.4.4 Others
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Process Development
  12.5.2 Upstream
  12.5.3 Downstream
 12.6 Historic and Forecasted Market Size By End-Users
  12.6.1 Pharmaceutical Companies
  12.6.2 Biopharmaceutical Companies
  12.6.3 CMOS & CROS
  12.6.4 Academic & Research Institute
  12.6.5 Others
 12.7 Historic and Forecast Market Size by Country
  12.7.1 China
  12.7.2 India
  12.7.3 Japan
  12.7.4 Singapore
  12.7.5 Australia
  12.7.6 New Zealand
  12.7.7 Rest of APAC

Chapter 13: Middle East & Africa Bioprocess Containers Market Analysis, Insights and Forecast, 2016-2028
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 2D Bioprocess Containers
  13.4.2 3D Bioprocess Containers
  13.4.3 Tank Liners
  13.4.4 Others
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Process Development
  13.5.2 Upstream
  13.5.3 Downstream
 13.6 Historic and Forecasted Market Size By End-Users
  13.6.1 Pharmaceutical Companies
  13.6.2 Biopharmaceutical Companies
  13.6.3 CMOS & CROS
  13.6.4 Academic & Research Institute
  13.6.5 Others
 13.7 Historic and Forecast Market Size by Country
  13.7.1 Turkey
  13.7.2 Saudi Arabia
  13.7.3 Iran
  13.7.4 UAE
  13.7.5 Africa
  13.7.6 Rest of MEA

Chapter 14: South America Bioprocess Containers Market Analysis, Insights and Forecast, 2016-2028
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 2D Bioprocess Containers
  14.4.2 3D Bioprocess Containers
  14.4.3 Tank Liners
  14.4.4 Others
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Process Development
  14.5.2 Upstream
  14.5.3 Downstream
 14.6 Historic and Forecasted Market Size By End-Users
  14.6.1 Pharmaceutical Companies
  14.6.2 Biopharmaceutical Companies
  14.6.3 CMOS & CROS
  14.6.4 Academic & Research Institute
  14.6.5 Others
 14.7 Historic and Forecast Market Size by Country
  14.7.1 Brazil
  14.7.2 Argentina
  14.7.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. BIOPROCESS CONTAINERS MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. BIOPROCESS CONTAINERS MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. BIOPROCESS CONTAINERS MARKET COMPETITIVE RIVALRY
TABLE 005. BIOPROCESS CONTAINERS MARKET THREAT OF NEW ENTRANTS
TABLE 006. BIOPROCESS CONTAINERS MARKET THREAT OF SUBSTITUTES
TABLE 007. BIOPROCESS CONTAINERS MARKET BY TYPE
TABLE 008. 2D BIOPROCESS CONTAINERS MARKET OVERVIEW (2016-2028)
TABLE 009. 3D BIOPROCESS CONTAINERS MARKET OVERVIEW (2016-2028)
TABLE 010. TANK LINERS MARKET OVERVIEW (2016-2028)
TABLE 011. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 012. BIOPROCESS CONTAINERS MARKET BY APPLICATION
TABLE 013. PROCESS DEVELOPMENT MARKET OVERVIEW (2016-2028)
TABLE 014. UPSTREAM MARKET OVERVIEW (2016-2028)
TABLE 015. DOWNSTREAM MARKET OVERVIEW (2016-2028)
TABLE 016. BIOPROCESS CONTAINERS MARKET BY END-USERS
TABLE 017. PHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 018. BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
TABLE 019. CMOS & CROS MARKET OVERVIEW (2016-2028)
TABLE 020. ACADEMIC & RESEARCH INSTITUTE MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA BIOPROCESS CONTAINERS MARKET, BY TYPE (2016-2028)
TABLE 023. NORTH AMERICA BIOPROCESS CONTAINERS MARKET, BY APPLICATION (2016-2028)
TABLE 024. NORTH AMERICA BIOPROCESS CONTAINERS MARKET, BY END-USERS (2016-2028)
TABLE 025. N BIOPROCESS CONTAINERS MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE BIOPROCESS CONTAINERS MARKET, BY TYPE (2016-2028)
TABLE 027. EUROPE BIOPROCESS CONTAINERS MARKET, BY APPLICATION (2016-2028)
TABLE 028. EUROPE BIOPROCESS CONTAINERS MARKET, BY END-USERS (2016-2028)
TABLE 029. BIOPROCESS CONTAINERS MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC BIOPROCESS CONTAINERS MARKET, BY TYPE (2016-2028)
TABLE 031. ASIA PACIFIC BIOPROCESS CONTAINERS MARKET, BY APPLICATION (2016-2028)
TABLE 032. ASIA PACIFIC BIOPROCESS CONTAINERS MARKET, BY END-USERS (2016-2028)
TABLE 033. BIOPROCESS CONTAINERS MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET, BY TYPE (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET, BY APPLICATION (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET, BY END-USERS (2016-2028)
TABLE 037. BIOPROCESS CONTAINERS MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA BIOPROCESS CONTAINERS MARKET, BY TYPE (2016-2028)
TABLE 039. SOUTH AMERICA BIOPROCESS CONTAINERS MARKET, BY APPLICATION (2016-2028)
TABLE 040. SOUTH AMERICA BIOPROCESS CONTAINERS MARKET, BY END-USERS (2016-2028)
TABLE 041. BIOPROCESS CONTAINERS MARKET, BY COUNTRY (2016-2028)
TABLE 042. THERMO FISHER SCIENTIFIC: SNAPSHOT
TABLE 043. THERMO FISHER SCIENTIFIC: BUSINESS PERFORMANCE
TABLE 044. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
TABLE 045. THERMO FISHER SCIENTIFIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. DANAHER CORPORATION: SNAPSHOT
TABLE 046. DANAHER CORPORATION: BUSINESS PERFORMANCE
TABLE 047. DANAHER CORPORATION: PRODUCT PORTFOLIO
TABLE 048. DANAHER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. SARTORIUS STEDIM BIOTECH: SNAPSHOT
TABLE 049. SARTORIUS STEDIM BIOTECH: BUSINESS PERFORMANCE
TABLE 050. SARTORIUS STEDIM BIOTECH: PRODUCT PORTFOLIO
TABLE 051. SARTORIUS STEDIM BIOTECH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. RIM BIO: SNAPSHOT
TABLE 052. RIM BIO: BUSINESS PERFORMANCE
TABLE 053. RIM BIO: PRODUCT PORTFOLIO
TABLE 054. RIM BIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. FINESSE SOLUTIONS: SNAPSHOT
TABLE 055. FINESSE SOLUTIONS: BUSINESS PERFORMANCE
TABLE 056. FINESSE SOLUTIONS: PRODUCT PORTFOLIO
TABLE 057. FINESSE SOLUTIONS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. OPTIMUM PROCESSING INC.: SNAPSHOT
TABLE 058. OPTIMUM PROCESSING INC.: BUSINESS PERFORMANCE
TABLE 059. OPTIMUM PROCESSING INC.: PRODUCT PORTFOLIO
TABLE 060. OPTIMUM PROCESSING INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. MERCK MILLIPORE: SNAPSHOT
TABLE 061. MERCK MILLIPORE: BUSINESS PERFORMANCE
TABLE 062. MERCK MILLIPORE: PRODUCT PORTFOLIO
TABLE 063. MERCK MILLIPORE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. PARKER HANNIFIN CORP: SNAPSHOT
TABLE 064. PARKER HANNIFIN CORP: BUSINESS PERFORMANCE
TABLE 065. PARKER HANNIFIN CORP: PRODUCT PORTFOLIO
TABLE 066. PARKER HANNIFIN CORP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. LONZA GROUP AG: SNAPSHOT
TABLE 067. LONZA GROUP AG: BUSINESS PERFORMANCE
TABLE 068. LONZA GROUP AG: PRODUCT PORTFOLIO
TABLE 069. LONZA GROUP AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. AVANTOR INC.: SNAPSHOT
TABLE 070. AVANTOR INC.: BUSINESS PERFORMANCE
TABLE 071. AVANTOR INC.: PRODUCT PORTFOLIO
TABLE 072. AVANTOR INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. GENERAL ELECTRIC COMPANY: SNAPSHOT
TABLE 073. GENERAL ELECTRIC COMPANY: BUSINESS PERFORMANCE
TABLE 074. GENERAL ELECTRIC COMPANY: PRODUCT PORTFOLIO
TABLE 075. GENERAL ELECTRIC COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 075. SAINT- GOBAIN S.A.: SNAPSHOT
TABLE 076. SAINT- GOBAIN S.A.: BUSINESS PERFORMANCE
TABLE 077. SAINT- GOBAIN S.A.: PRODUCT PORTFOLIO
TABLE 078. SAINT- GOBAIN S.A.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 078. GE HEALTHCARE: SNAPSHOT
TABLE 079. GE HEALTHCARE: BUSINESS PERFORMANCE
TABLE 080. GE HEALTHCARE: PRODUCT PORTFOLIO
TABLE 081. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 081. MEISSNER: SNAPSHOT
TABLE 082. MEISSNER: BUSINESS PERFORMANCE
TABLE 083. MEISSNER: PRODUCT PORTFOLIO
TABLE 084. MEISSNER: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 084. FLUIDS CONTROL: SNAPSHOT
TABLE 085. FLUIDS CONTROL: BUSINESS PERFORMANCE
TABLE 086. FLUIDS CONTROL: PRODUCT PORTFOLIO
TABLE 087. FLUIDS CONTROL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 087. NETA SCIENTIFIC INCORPORATED INC.: SNAPSHOT
TABLE 088. NETA SCIENTIFIC INCORPORATED INC.: BUSINESS PERFORMANCE
TABLE 089. NETA SCIENTIFIC INCORPORATED INC.: PRODUCT PORTFOLIO
TABLE 090. NETA SCIENTIFIC INCORPORATED INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 090. ALLPAQ PACKAGING GROUP: SNAPSHOT
TABLE 091. ALLPAQ PACKAGING GROUP: BUSINESS PERFORMANCE
TABLE 092. ALLPAQ PACKAGING GROUP: PRODUCT PORTFOLIO
TABLE 093. ALLPAQ PACKAGING GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 093. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 094. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 095. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 096. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. BIOPROCESS CONTAINERS MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. BIOPROCESS CONTAINERS MARKET OVERVIEW BY TYPE
FIGURE 012. 2D BIOPROCESS CONTAINERS MARKET OVERVIEW (2016-2028)
FIGURE 013. 3D BIOPROCESS CONTAINERS MARKET OVERVIEW (2016-2028)
FIGURE 014. TANK LINERS MARKET OVERVIEW (2016-2028)
FIGURE 015. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 016. BIOPROCESS CONTAINERS MARKET OVERVIEW BY APPLICATION
FIGURE 017. PROCESS DEVELOPMENT MARKET OVERVIEW (2016-2028)
FIGURE 018. UPSTREAM MARKET OVERVIEW (2016-2028)
FIGURE 019. DOWNSTREAM MARKET OVERVIEW (2016-2028)
FIGURE 020. BIOPROCESS CONTAINERS MARKET OVERVIEW BY END-USERS
FIGURE 021. PHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 022. BIOPHARMACEUTICAL COMPANIES MARKET OVERVIEW (2016-2028)
FIGURE 023. CMOS & CROS MARKET OVERVIEW (2016-2028)
FIGURE 024. ACADEMIC & RESEARCH INSTITUTE MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA BIOPROCESS CONTAINERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE BIOPROCESS CONTAINERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC BIOPROCESS CONTAINERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA BIOPROCESS CONTAINERS MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA BIOPROCESS CONTAINERS MARKET OVERVIEW BY COUNTRY (2016-2028)